Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 23, 1999
Issued Date -
N/A
app pub date -
Jun 6, 1995
filing date -
Mar 7, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Attenuated recombinant viruses containing DNA encoding a calicivirus antigen such as a RHDV antigen, e.g., a capsid gene, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom and antibodies generated by the viruses and gene products have several preventive, therapeutic and diagnostic uses. The DNA from the viruses can be used for probes or for primers.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully